Acalakast™ 100 Capsules Acalakast™ 100 Capsules contain Acalabrutinib, a Bruton tyrosine kinase (BTK) inhibitor used to treat certain B-cell blood cancers. It works by blocking BTK, helping slow the growth and survival of malignant B cells in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL). It is used under the supervision of an oncologist.

Effects & Benefits Helps slow the growth and spread of cancer cells. Effective in treating CLL, SLL, and MCL. Targets BTK to inhibit malignant B-cell proliferation. Helps improve progression-free survival. Oral capsule for convenient long-term therapy. Supports effective management of B-cell malignancies.